| 2001 |
Seroprevalence of Toxoplasma gondii among patients with schizophrenia and bipolar disorder in Upper Egypt: a comparative study with a control group |
Department of Neurology and Psychiatry |
2020 |
| 2002 |
Seroprevalence of Toxoplasma gondii among patients with schizophrenia and bipolar disorder in Upper Egypt: a comparative study with a control group |
Department of Neurology and Psychiatry |
2020 |
| 2003 |
Serum 14-3-3η protein is associated with clinical and serologic features of Sjögren's syndrome in patients with systemic lupus erythematosus: a cross-sectional analysis. |
Department of Rheumatology ,Rehabilitation & physical medicine |
2020 |
| 2004 |
Serum and urine monocyte chemoattractant protein-1 as a markers for lupus nephritis. |
Internal Medicine |
2020 |
| 2005 |
Serum interleukin-22 and C-reactive protein in patients with vitiligo: a case–control study on 35 Egyptian patients
|
Department of Biochemistry |
2020 |
| 2006 |
Serum interleukin-22 and C-reactive protein in patients with vitiligo: a case–control study on 35 Egyptian patients
|
Department of Dermatology |
2020 |
| 2007 |
Serum interleukin-22 and C-reactive protein in patients with vitiligo: a case–control study on 35 Egyptian patients
|
Department of Dermatology |
2020 |
| 2008 |
Serum interleukin-22 and C-reactive protein in patients with vitiligo: a case–control study on 35 Egyptian patients
|
Department of Clinical Pathology |
2020 |
| 2009 |
Serum level of S100B in vitiligo patients: Is it a marker of disease activity? |
Department of Dermatology |
2020 |
| 2010 |
Serum level of S100B in vitiligo patients: Is it a marker of disease activity? |
Department of Biochemistry |
2020 |
Do you have any questions? 
